全球馬藥和補充劑市場規模（按類型、分銷管道、區域覆蓋範圍和預測）

馬藥和補充劑的市場規模和預測

2024 年馬藥和補充劑市場規模為 10.8548 億美元，預計到 2031 年將達到 14.3934 億美元，2024 年至 2031 年的複合年增長率為 3.59%。由於人們對馬藥物和補充劑產品的認識不斷提高，以及對馬草藥消化劑、飼料和能量補充劑的需求不斷增加，全球馬藥物和補充劑市場正在強勁增長。全球馬藥和補充劑市場報告提供了對市場的整體評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

全球馬藥和補充劑市場定義

馬藥和補充劑是專門用於治療疾病或改善營養的藥物和補充劑。這些藥物和營養補充劑包括維生素、蛋白質、電解質、能量補充劑等。這些醫療設備主要用於驢子、馬和斑馬，以治癒傷口並提供能量以保持身體健康和強壯。

馬藥和補充劑是用於改善營養狀況和治療疾病的藥物和補充劑。這些藥物和營養補充劑含有蛋白質、維生素、能量補充劑和電解質。馬藥和補充劑為馬、驢和斑馬提供能量來治癒受傷並保持強壯和健康。各國政府和許多動物衛生機構已向一些馬匹飼養員和馴馬師提出了關於馬匹生長和健康所需的優質、健康營養和補充劑的擔憂。此外，它還提供資訊並提高人們對預防各種疾病和治療某些疾病的必要性的認識。

動物營養補充品（營養保健品）是含有一種或多種營養成分的口服產品，旨在補充飲食。這些成分包括維生素、礦物質、草藥等植物、胺基酸（蛋白質的組成部分）、酵素、器官組織、腺體、代謝物、萃取物、濃縮物和其他物質。補充劑有多種劑型，包括丸劑、顆粒劑、粉末、糊劑、液體、注射劑（靜脈或肌肉注射）和片劑。

馬藥和補充劑的全球市場概覽

全球馬藥和補充劑市場是由人們對馬藥和補充劑的認識不斷提高所推動的。隨著馬匹飼養員和馴馬師越來越多地選擇有機產品，對馬匹的草藥消化助劑、飼料和能量補充劑的需求正在增加。此舉旨在推動預測期內藥品和補充劑市場的成長。

此外，由於馬飼養者決定採用有機食品，人們對馬藥和補充劑、草本飼料的認識不斷提高，以及對消化和能量補充劑的需求增加，也推動了需求的成長。此外，賽馬和馬術運動產業正在推動對馬藥品的需求，因為馬的健康對於這些產業的發展至關重要。在某些賽事中，健康的馬匹會為與賽馬相關的博彩業帶來動力。因此，許多馴馬師和飼養員使用優質藥物來控制和治療疾病，以保持他們的馬匹適合比賽。嚴重依賴馬匹健康的賽馬和馬術運動產業正在推動對馬藥品的需求。這就是為什麼大多數馴馬師和飼養員使用高品質的藥物來預防疾病和治療疾病，以便他們的馬匹能夠參加比賽。

然而，對藥品和營養補充劑的嚴格監管是市場的主要障礙。其他投注和賭博途徑的可用性正在對已開發國家的馬匹相關行業產生影響。此舉旨在減緩全球馬藥品和營養補充劑市場的成長。

賽馬運動在某些地區的發展預計將為全球馬匹藥品和營養保健品市場的主要參與者提供擴張機會。此外，馬匹育種的下降導致馬匹數量下降，預計在預測期內將繼續成為市場的主要課題。

目錄

第1章：全球馬藥和補充劑市場：簡介

• 市場概況
• 調查範圍
• 先決條件

第 2 章執行摘要

第3章 驗證市場研究研究方法

• 數據挖掘
• 驗證
• 一次資料
• 數據源列表

第4章全球馬藥和補充劑市場展望

• 概述
• 市場動態
  • 促進因素
  • 阻礙因素
  • 機會
• 波特的五力模型
• 價值鏈分析

第5章全球馬藥和補充劑市場：按產品類型

• 概述
• 藥品
• 補充

第6章全球馬藥和補充劑市場：按分銷管道

• 概述
• 動物醫院
• 藥店
• 其他

第7章全球馬藥和補充劑市場：按地區

• 概述
• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 亞太其他地區
• 世界其他地區
  • 拉丁美洲
  • 中東

第8章全球馬藥品和補充品市場：競爭格局

• 概述
• 各公司市場排名
• 主要發展策略

第9章 公司簡介

• Zoetis
• Boehringer Ingelheim
• Merck & Co
• Elanco
• Bayer
• Ceva Sante Animale
• Virbac
• Affymetrix
• Celltrion
• Vetoquinol

第10章 主要進展

• 產品發佈/開發
• 併購
• 業務拓展
• 夥伴關係和聯盟

第11章附錄

• 相關研究

Equine Pharmaceuticals And Supplements Market Size And Forecast

Equine Pharmaceuticals and Supplements Market size was valued at USD 1085.48 Million in 2024 and is projected to reach USD 1439.34 Million by 2031, at a CAGR of 3.59% from 2024 to 2031. The global equine pharmaceuticals and supplements market has witnessed strong growth owing to the increasing awareness about equine pharmaceuticals and supplements products and increasing demand for herbal digestive, feed, and energy supplements for horses. The Global Equine Pharmaceuticals and Supplements Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Equine Pharmaceuticals and Supplements Market Definition

Equine pharmaceuticals and supplements are medicines or supplements explicitly used to treat disease or improve nutrition. These medicines and dietary supplements include vitamins, proteins, electrolytes and energy supplements. These medical devices are primarily used on donkeys, horses and zebras to heal injuries and provide these animals with energy to keep them healthy and strong.

Equine pharmaceuticals and supplements are medicines or supplements explicitly used to improve nutrition and cure disease. These medicines and dietary supplements contain proteins, vitamins, energy supplements and electrolytes. Equine medication and supplements give horses, donkeys and zebras the energy to heal injuries and stay strong and healthy. Governments and many animal health agencies have raised concerns among several horse industry horse breeders and trainers about the need for good, healthy nutrition and nutritional supplements for the growth and health of horses. In addition, it provides information and raises awareness of the need to prevent various diseases and treat some.

Also, veterinary nutritional supplements (nutraceuticals) are oral products that contain one or more dietary ingredients intended to supplement the diet. These ingredients include vitamins, minerals, herbs or other botanicals, amino acids (the building blocks of proteins), and substances such as enzymes, organ tissue, glands, metabolites, extracts, or concentrates. Supplements are available in many formulations, including pellets, granules, powders, pastes, liquids, injections (intravenous or intramuscular), and pills.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Equine Pharmaceuticals and Supplements Market Overview

The global equine pharmaceuticals and supplements market is driven by increasing awareness of equine pharmaceuticals and supplements. With horse breeders and trainers choosing organic products, demand for herbal digestives, feeds and energy supplements for horses is increasing. It is designed to drive the growth of the pharmaceutical and supplements market during the forecast period.

Moreover, increasing awareness of equine medicines and supplements, increasing demand for herbal feed, and digestive and energy supplements as horse breeders decide to go organic are driving demand for the product. Further, the horseracing and equestrian sports industries are driving the need for equine medicines, as horses' health is essential to the growth of these industries. Healthy horses in specific disciplines give impetus to the betting and gambling industry associated with horse racing. Therefore, most horse trainers and breeders use superior medicines to limit and cure ailments to keep horses in good shape for racing. The horse racing and equestrian sports industry, which relies heavily on horse health, drives demand for equine medicines. As a result, most horse trainers and breeders use high-quality pharmaceuticals to prevent disease and cure disorders to ensure their horses are ready to race.

However, stringent regulations on pharmaceuticals and dietary supplements are significantly hampering the market. The availability of alternative betting and gambling vehicles impacts the horse-related industry in developed countries. It is intended to slow down the growth of the global equine medicines and nutritional supplements market.

The development of horse racing in specific geographic regions is expected to provide expansion opportunities for key players in the global equine medicines and nutritional supplements market. Furthermore, declining horse breeding will lead to declining horse populations and is expected to remain a significant challenge for the market during the forecast period.

Global Equine Pharmaceuticals and Supplements Market Segmentation Analysis

The Global Equine Pharmaceuticals and Supplements Market is segmented based on Type, Distribution Channel, and Geography.

Equine Pharmaceuticals and Supplements Market, By Type

• Pharmaceuticals
• Supplements

Based on Type, the market is bifurcated into Pharmaceuticals and Supplements. The Pharmaceuticals segment is estimated to witness the highest CAGR for the forecast period. The factors attributed to the segment's growth are associated with the increasing demand for pharmaceuticals to limit illnesses and heal diseases so that the horses are in good shape for the races, thus promulgating segment growth.

Equine Pharmaceuticals and Supplements Market, By Distribution Channel

• Veterinary Hospitals
• Drugstores
• Others

Based on Distribution Channel, the market is bifurcated into Veterinary Hospitals, Drugstores, and Others. The Drugstore's segment is estimated to witness the highest CAGR for the forecast period. The factors attributed to the segment's growth are associated with the increasing owner preference for treating horses in hospitals and improved availability of veterinary supplements. Also, the massive availability of equine pharmaceuticals at drug stores. These medications are used to treat horses, donkeys and zebras.

Equine Pharmaceuticals and Supplements Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• The Asia-Pacific region is anticipated to become the fastest-growing equine pharmaceuticals and supplements market due to the development of horseracing and other horse-related activities in countries such as China, Australia, and New Zealand. With important horse races such as the Dubai World Cup, growth in the Middle East for equine breeding and other related equine sporting and non-sporting sectors is noteworthy and expected to boost the development of the Middle East equine medicines and supplements market.

Key Players

• The "Global Equine Pharmaceuticals and Supplements Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Zoetis, Boehringer Ingelheim, Merck & Co, Elanco, Bayer, Ceva Sante Animale, Virbac, Vetoquinol, Affymetrix, Celltrion.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Pharmaceuticals
• 5.3 Supplements

6 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

• 6.1 Overview
• 6.2 Veterinary Hospitals
• 6.3 Drugstores
• 6.4 Others

7 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East

8 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Zoetis
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Boehringer Ingelheim
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Merck & Co
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Elanco
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Bayer
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Ceva Sante Animale
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Virbac
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Affymetrix
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Celltrion
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Vetoquinol
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research